Neuroscience startup at URI to focus on Alzheimer’s, Parkinson’s

A few scientists who once worked together for the global pharmaceutical company Pfizer, in Groton, Connecticut, are now collaborating with the University of Rhode Island. The team, which is calling itself MindImmune, is working to build a company they hope will find treatment for diseases of the brain — Alzheimer’s, Parkinson’s and other neuro-degenerative disorders, said Richard G. Horan, a managing director of the Slater Technology Fund. The scientists recently approached URI about locating on the Kingston campus, Paula Grammas, director of URI’s George & Anne Ryan Institute for Neuroscience, told a group of nearly 300 business people last week at the Santander Bank-Greater Providence Chamber of Commerce economic-outlook breakfast. But interested venture-capital investors wanted the scientists to locate in Cambridge, Massachusetts, Grammas said. URI and the Slater Technology Fund…

Link to Full Article: Neuroscience startup at URI to focus on Alzheimer’s, Parkinson’s

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!